Consider Endari for Patients on Hydroxyurea Who Still Have Sickle Cell Crises

L-glutamine (Endari, en-DAH-ree) is the first sickle cell treatment to be approved in almost 20 years.

L-glutamine is for patients 5 years and older to reduce acute sickle cell complications...such as pain crises, acute chest syndrome, etc.

It's thought to work by reducing oxidative damage to "sickled" red blood cells. This may prevent the cells from adhering to blood vessels, causing thrombosis and reducing blood flow.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals